Iterum Therapeutics plc (ITRMF) Total Debt (2018 - 2024)

Iterum Therapeutics has reported Total Debt for 7 years, with the latest figure at $14.5 million in Q4 2024.

• On a quarterly basis, Total Debt rose 26.28% year-over-year to $14.5 million in Q4 2024; TTM through Dec 2024 was $14.5 million, a 26.28% increase from a year earlier, with the FY2024 full-year figure at $14.5 million, up 26.28% from the prior year.
• Total Debt was $14.5 million for Q4 2024 at Iterum Therapeutics, up from $13.7 million in the prior quarter.
• The five-year high for Total Debt was $57.7 million in Q4 2020, with the low at $9.9 million in Q3 2022.
• Average Total Debt over 5 years is $23.2 million, with a median of $13.3 million recorded in 2024.
• The sharpest annual moves came in 2020 and 2021: Total Debt surged 329.8% in 2020, then sank 74.67% in 2021.
• Over 5 years, Total Debt stood at $57.7 million in 2020, then sank by 74.67% to $14.6 million in 2021, then fell by 29.59% to $10.3 million in 2022, then rose by 11.3% to $11.5 million in 2023, then grew by 26.28% to $14.5 million in 2024.
• The last three Total Debt figures came in at $14.5 million (Q4 2024), $13.7 million (Q3 2024), and $13.0 million (Q2 2024), per Business Quant data.